|
?:authorAffiliation
|
-
[\'Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.\', \'Soteria Biotherapeutics, San Francisco, CA, USA.\', \'Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.\', \'Division of Experimental Medicine, University of California, San Francisco, San Francisco CA, USA.\', \'Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.\', \'Chan Zuckerberg Biohub, San Francisco, CA, USA.\', \'Departments of Medicine and of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.\', \'Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA. jim.wells@ucsf.edu.\', \'Chan Zuckerberg Biohub, San Francisco, CA, USA. jim.wells@ucsf.edu.\', \'Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA. jim.wells@ucsf.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}